CLC Number:
| [1] Pachlopnik Schmid J, Canioni D, Moshous D, et al. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1(XLP-1/SAP deficiency)versus type 2(XLP-2/XIAP deficiency)[J]. Blood, 2011, 117(5): 1522-1529. [2] Tangye SG. XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP[J]. J Clin Immunol, 2014, 34(7): 772-779. [3] 郝俊楠,王志,姜健,等.X连锁淋巴组织增生综合征-2型1例报告并文献复习[J].精准医学杂志, 2020, 35(1): 41-44. [4] Coffey AJ, Brooksbank RA, Brandau O, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene[J]. Nat Genet, 1998, 20(2): 129-135. [5] Liu XY, Nie YB, Chen XJ,et al. Adult onset type 2 familial hemophagocytic lymphohistiocytosis with PRF1 c.65delC/c.163C>T compound heterozygous mutations: A case report[J]. World J Clin Cases, 2021, 9(10): 2289-2295. [6] Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007, 48(2): 124-131. [7] Holle JR, Marsh RA, Holdcroft AM, et al. Hemophagocytic lymphohistiocytosis in a female patient due to a heterozygous XIAP mutation and skewed X chromosome inactivation[J]. Pediatr Blood Cancer, 2015, 62(7): 1288-1290. [8] 孙晨曦,王永静,李爱,等. 1例罕见成年XLP-1病例报道[J]. 山东大学学报(医学版), 2022, 60(3): 117-120. [9] Panchal N, Booth C, Cannons JL, et al. X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective[J]. Front Immunol, 2018, 9: 666. doi:10.3389/fimmu.2018.00666. [10] Xu T, Zhao Q, Li W, et al. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic[J]. Eur J Pediatr, 2020, 179(2): 327-338. [11] Kiykim A, Eker N, Surekli O, et al. Malignancy and lymphoid proliferation in primary immune deficiencies; hard to define, hard to treat[J]. Pediatric blood cancer, 2020,67(2): e28091. doi:10.1002/pbc.28091. [12] Booth C, Gilmour KC, Veys P, et al. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease[J]. Blood, 2011, 117(1): 53-62. |
| [1] | . [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 117-120. |
| [2] | HAN Kangkang, CUI Liwei, PENG Cheng, XUE Yuwen, XIAO Wei. Multiple serous effusion complicated with Warburg effect: a case report of diffuse large B-cell lymphoma and literature review [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 80-87. |
| [3] | . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(10): 111-112. |
| [4] | . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(2): 109-112. |
| [5] |
FANG Xiaosheng, LIU Xin, WANG Xin . Expressions of heat shock protein 70 and 90α in nonHodgkin′s lymphoma and its clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(04): 83-86. |
| [6] | . [J]. Journal of Shandong University (Health Sciences), 2022, 60(10): 120-124. |
| [7] | . [J]. Journal of Shandong University (Health Sciences), 2018, 56(6): 87-90. |
|